´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 5) : 2022-04-03±³À°ÀÏÀÚ : 2022-04-03
±³À°Àå¼Ò : (¿Â, ¿ÀÇÁ¶óÀÎ º´Çà) ¿ÀÇÁ¶óÀÎ Àå¼Ò: ¼¿ï ÄÚ¿¢½º
±³À°ÁÖÁ¦ :
(¿Â-¿ÀÇÁº´Çà) APASL 2022 (DAY 5)ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : APASL 2022 Áغñ»ç¹«±¹
¿¬¶ôó : 02-707-0091
À̸ÞÀÏ :
apasl2022@insession.co.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 800,000¿ø
ºñ°í Category Early Bird Rate Regular Rate Onsite Rate December 31(Fri), 2021 February 20(Sun), 2022 Off-line Virtual Off-line Virtual Off-line VirtualAPASL Member USD 300 USD200 USD400 USD300 USD 500 USD 400Non APASL Member USD 500 USD 300 USD 600 USD 400 USD 700 USD 500Trainee/Resident/Nurse USD 200 USD 100 USD 300 USD 200 USD 400 USD 300Accompanying Person USD 150 - USD 200 - USD 300 -Industry Partner USD 600 USD 600 USD 700 USD 700 USD 800 USD 800 / *»çÀüµî·Ï2022³â 2¿ù 20ÀÏ(ÀÏ)±îÁö [ÇöÀå] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 15¸¸¿ø, µ¿¹ÝÀÚ 15¸¸¿ø, Industry Partner 70¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 25¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 12¸¸¿ø, Industry Partner 70¸¸¿ø, *ÇöÀåµî·Ï [ÇöÀå] Àü¹®ÀÇ 35¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 18¸¸¿ø, µ¿¹ÝÀÚ 18¸¸¿ø, Industry Partner 80¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ/Àü°øÀÇ/°£È£»ç 15¸¸¿ø, Industry Partner 80¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-03 101, 1F 08:30~08:40 Alcohol-induced glutamate vesicles trigger inflammatory liver injury through Kupffer cell activation Keungmo Yang(Korea advanced institute of science and technology)
±³À°½Ã°£ 04-03 101, 1F 08:40~08:50 In vivo RNA-interference (RNAi) screen identifies potential regulators of liver regeneration and disease Viktoriia Iakovleva(Genome Institute of Singapore)
±³À°½Ã°£ 04-03 101, 1F 08:50~09:00 Risk of hepatocellular carcinoma, but not hepatic decompensation, persists beyond 7 years after hepatitis B surface antigen seroclearance: a territory-wide cohort of 9,769 patients Terry Cheuk-Fung Yip(Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong)
±³À°½Ã°£ 04-03 101, 1F 09:00~09:10 Progress towards hepatitis C elimination: The feasibility and success of a nurse and harm reduction practitioner led model of care utilising rapid point of care HCV RNA testing at a medically supervis Michael Macisaac(St Vincent)
±³À°½Ã°£ 04-03 101, 1F 09:10~09:20 LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis Gang Li(NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China;)
±³À°½Ã°£ 04-03 101, 1F 09:20~09:30 L-ornithine L-aspartate in acute treatment of severe Hepatic encephalopathy: A double-blind randomized controlled trial Arpan Jain(Department of Gastroenterology, GB Pant Hospital, New Delhi)
±³À°½Ã°£ 04-03 101, 1F 09:30~09:40 The Accuracy of Microvascular Invasion Prediction Based on Radiomics Methods in Hepatocellular Carcinoma: a Systematic Review and Meta-Analysis of Diagnostic Study Mochamad Afifudin(Universitas Islam Indonesia)
±³À°½Ã°£ 04-03 101, 1F 09:40~09:50 Surgical outcomes of pure laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma Kyeong Deok Kim(Samsung Medical Center)
±³À°½Ã°£ 04-03 101, 1F 09:50~10:00 Long term post-transplant survival outcome following the bridging locoregional therapy in hepatocellular carcinoma patients: A systematic review and meta-analysis study Alan Chuncharunee(Division of gastroenterology and hepatology, Department of internal medicine, Faculty of medicine, Ramathibodi hospital, Mahidol University, Bangkok, Thailand)
ÈÞ½Ä 04-03 101, 1F 10:00~10:10 Break ()
±³À°½Ã°£ 04-03 101, 1F 10:10~10:40 Hepatitis Jun Yong Park(Yonsei University College of Medicine)
±³À°½Ã°£ 04-03 101, 1F 10:40~11:10 Cirrhosis and others Dong Hyun Sinn(Sungkyunkwan University School of Medicine)
±³À°½Ã°£ 04-03 101, 1F 11:10~11:40 Liver cancer Ju Hyun Shim(University of Ulsan College of Medicine)
±³À°½Ã°£ 04-03 102, 1F 08:30~08:40 Japan Osamu Yokosuka(Graduate School of Medicine, Chiba University)
±³À°½Ã°£ 04-03 102, 1F 08:40~08:50 Taiwan Han-Chieh Lin(Taipei Veterans General Hospital)
±³À°½Ã°£ 04-03 102, 1F 08:50~09:00 Philippines Diana A Payawal(Fatima University Medical Center)
±³À°½Ã°£ 04-03 102, 1F 09:00~09:10 Thailand Tawesak Tanwandee(Siriraj Hospital, Mahidol University)
±³À°½Ã°£ 04-03 102, 1F 09:10~09:20 Armenia Hasmik Ghazinyan(Norq Clinical Hospital of Infectious Diseases)
±³À°½Ã°£ 04-03 102, 1F 09:20~09:30 Turkey A.Kadir Dokmeci(Ankara University School of Medicine)
±³À°½Ã°£ 04-03 102, 1F 09:30~09:40 Pakistan Saeed Sadiq Hamid(Aga Khan University and Hospital)
±³À°½Ã°£ 04-03 102, 1F 09:40~09:50 Malaysia Rosmawati Mohamed(Faculty of Medicine, University of Malaya)
ÈÞ½Ä 04-03 101, 1F 09:50~10:10 Break ()
±³À°½Ã°£ 04-03 102, 1F 10:10~10:20 India Barjesh C Sharma(G B Pant Hospital)
±³À°½Ã°£ 04-03 102, 1F 10:20~10:30 China Jinlin Hou(Nanfang Hospital, Southern Medical University)
±³À°½Ã°£ 04-03 102, 1F 10:30~10:40 Vietnam Trung Hai Le(Hanoi General Hospital)
±³À°½Ã°£ 04-03 102, 1F 10:40~10:50 Indonesia Rino A Gani(Cipto Mangunkusumo Hospital)
±³À°½Ã°£ 04-03 102, 1F 10:50~11:00 Kazakhstan Alexander V. Nersesov(Kazakh National Medical University)
±³À°½Ã°£ 04-03 102, 1F 11:00~11:10 Australia Darrell Crawford(The University of Queensland)
±³À°½Ã°£ 04-03 102, 1F 11:10~11:20 Mongolia Oidov Baatarkhuu(Mongolian National University of Medical Sciences)
±³À°½Ã°£ 04-03 102, 1F 11:20~11:30 Korea Si Hyun Bae(College of Medicine, The Catholic University of Korea)